American Heart Journal
Volume 158, Issue 2 , Pages 177-184 , August 2009

Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study

  • Ludovic Drouet, MD, PhD

      Affiliations

    • Department of Angio-Hematology, Hôpital Lariboisière, AP-HP Paris, France
    • University of Paris VII-Denis Diderot, Paris, France
    • Corresponding Author InformationReprint requests: Ludovic Drouet, MD, PhD, Angio-Hematology Department, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris cedex 10, Paris, France.
    • ,
  • Claire Bal dit Sollier, MB

      Affiliations

    • Experimental Thrombosis and Atherosclerosis Laboratory, Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France
    • ,
  • Jack Martin, MD

      Affiliations

    • Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital, Bryn Mawr, PA

Received 29 January 2009 ,Accepted 18 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Randomized clinical trial no.: NCT00622115.

 Prof Drouet reports receiving grant support from sanofi-aventis, Eli Lilly, and GSK, and consulting and lecture fees from sanofi-aventis, BMS, AstraZeneca, The Medicine Company, GSK, Servier, Cordis and Boehringer-Ingelheim. Dr Bal dit Sollier reports being an employee of the Blood and Vessel Institute and receiving grant support from sanofi-aventis and Eli Lilly. Dr Martin reports receiving consulting and lecture fees from sanofi-aventis.

PII: S0002-8703(09)00386-X

doi: 10.1016/j.ahj.2009.05.022

American Heart Journal
Volume 158, Issue 2 , Pages 177-184 , August 2009

Article Tools

* Image Usage & Resolution